Skip to main content
. 2021 Sep 27;7(2):409–427. doi: 10.1007/s41030-021-00174-5
Success in treating asthma and chronic obstructive pulmonary disease (COPD) may depend on inhaler choice.
Correct use of the Easyhaler® dry-powder inhaler (DPI) is less dependent on patients’ hand–breath coordination than use of a pressurized metered-dose inhaler (pMDI).
The Easyhaler delivers medication consistently and reliably at low respiratory rates (≤ 30 l/min) and inhalation volumes (down to 0.5 l), making it suitable for the majority of asthma and COPD patients.
In clinical studies, patients often express a preference for the Easyhaler over pMDIs and other devices. They report that it is easy to learn and use.
Switching an inhaler device to the Easyhaler may improve asthma and COPD control and can be done safely. Preferring DPIs to pMDIs is also a cost-effective way to reduce emissions of greenhouse gases.